IMPROVING THE PRINCIPLES OF TREATMENT IN PATIENTS WITH ZOONOTIC LEISHMANIASIS WITH THE IMMUNOMODULATOR GEPON AND METHYLENE BLUE USING THE ALT-VOSTOK DEVICE

Olim Bobomurodovich Rakhmatov Bukhara state medical institute. Uzbekistan

Abstract

The object of the study was 102 patients with zoonotic leishmaniasis aged from 2 to 65 years. The diagnosis of zoonotic leishmaniasis was established by clinical and epidemiological data and confirmed by the results of parasitological studies. We studied the duration of the clinical periods of zoonotic leishmaniasis against the background of complex therapy with methylene blue using the ALT-Vostok model-03device in the control group of 51 patients and complex therapy with methylene blue using the ALT-Vostok model-03 device and the immunomodulator Gepon in the main group of 51 patients. The results of the study showed that in patients of the main group, on the background of treatment with the ALT-Vostok model-03 device using the immunomodulator Gepon, the duration of the main periods was significantly reduced than in the control group in whom only methylene blue was treated with the ALT-Vostok model-03 device.

Keywords:

leishmaniasis, methylene blue, ALT-Vostok model-03 device, immunomodulator Gepon


Full Text:

PDF


References



References 1. Weekly epidemiological record of WHO. 29 June 2018, vol. 93, 26 (pp. 369–380) 2. The immunopathogenesis of atopic dermatitis and strategy of immunotherapy FA Maxmudov, II Latipov Novyy den v medistine, 53-57 3.Fight against leishmaniasis. Report to the meeting of the WHO Expert Committee on leishmaniasis Control, Geneva 11-26 March. 4. Dudchenko M.A., Lysenko B.F., Chelishvili A.L., Katlinskiy A.V., Ataullakhanov R.R., Complex treatment of trophic ulcers -2002, and Attending physician, No.10, 72-75. 5. The immunopathogenesis of atopic dermatitis and strategy of immunotherapy FA Maxmudov, II Latipov Novyy den v medistine, 53-57 6.Ataullkhanov R.I., Holmes R.D., Kaltinskiy A.V., Deryabin P.G., Narovlyanskiy A.N., Mezentseva M.V., Esrhov F.I., Antibiot Khimiotres 20002 47 (8) p 9-11. 7.Sillin D.S., Lyubomskaya O.V., Ershov F.I., Frolov V.M., Kutsyna G. Synthetic natural immunimodulators acting as interferon inducers. Current pharmaceutical design, 2009 15(11) p:1238- 1247 8.Gribencha S.B., Holmes R.D., Ataullakhanov R.I., Barinsky I.F. Antiviralactivity of the pepdite immunomodulator “Gepon”in experimental models of the rabies virus. Virology Question, 2003.48(4):p. 40-44 9. Improving the principles of treatment in patients with zoonotic leishmaniasis with the immunomodulator Gepon and methylene blue using the Alt Vostok apparatus Rakhmatov.O.B., K.M Farkhodovna The American Journal of Medical siences and pharmaceutical research 3

Refbacks

  • There are currently no refbacks.